Paradigm Biocapital Advisors’s Esperion Therapeutics ESPR Stock Holding History

Paradigm Biocapital Advisors’s Portfolio ESPR Stock Details ESPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell
2022 Q3	$11.5M	Buy
2022 Q2	$8.96M	Buy
2022 Q1	$5.37M	Buy
2021 Q4	$4.2M	Buy